The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Discover a study regime that included a treatment serum, a redness-reducing moisturizer, and sunscreen that showed promising ...

Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

In general, individuals with rosacea will want to avoid products containing salicylic acid due to the potential for side effects. Antibiotics, such as doxycycline (Oracea), and other treatments ...

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...

Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating ...

New research finds that topical ferulic acid significantly improves skin lesions and barrier function in patients with ...

"Treatment with topical ivermectin may improve the symptoms of rosacea through modulation of the skin microbiome beyond decreasing Demodex," the authors concluded. "The results of this study,” they ...

The U.S. Food and Drug Administration has approved Journey Medical's drug for the treatment of a long-term skin condition ...

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adultsCosibelimab PDUFA goal date of December 28 for ...